Parkinsonism in neurometabolic diseases

Anagianni, 2019, Genetic disorders of manganese metabolism, Current Neurology and Neuroscience Reports, 19, 10.1007/s11910-019-0942-y Antonini, 2005, Genetic, clinical, and imaging characterization of one patient with late-onset, slowly progressive, pantothenate kinase-associated neurodegeneration, Movement Disorders, 21, 417, 10.1002/mds.20774 Björkhem, 2010, Cerebrotendinous xanthomatosis: An inborn error in bile acid synthesis with defined mutations but still a challenge, Biochemical and Biophysical Research Communications, 396, 46, 10.1016/j.bbrc.2010.02.140 Brewer, 1987, Worsening of neurologic syndrome in patients with Wilsons disease with initial penicillamine therapy, Archives of Neurology, 44, 490, 10.1001/archneur.1987.00520170020016 Brockmann, 2011, GBA-associated PD presents with nonmotor characteristics, Neurology, 77, 276, 10.1212/WNL.0b013e318225ab77 Brunetti-Pierri, 2008, GM1 gangliosidosis: Review of clinical, molecular, and therapeutic aspects, Molecular Genetics and Metabolism, 94, 391, 10.1016/j.ymgme.2008.04.012 Chiapparini, 2011, The “Eye-of-the-Tiger” sign may be absent in the early stages of classic pantothenate kinase associated neurodegeneration, Neuropediatrics, 42, 159, 10.1055/s-0031-1285925 Chien, 2011, ATP13A2-related neurodegeneration (PARK9) without evidence of brain iron accumulation, Movement Disorders, 26, 1364, 10.1002/mds.23514 Cilia, 2016, Survival and dementia inGBA-associated Parkinsons disease: The mutation matters, Annals of Neurology, 80, 662, 10.1002/ana.24777 Członkowska, 2018, Wilson disease, Nature Reviews Disease Primers, 4, 10.1038/s41572-018-0018-3 Członkowska, 2018, Characteristics of a newly diagnosed Polish cohort of patients with neurological manifestations of Wilson disease evaluated with the unified Wilson’s Disease rating scale, BMC Neurology, 18, 10.1186/s12883-018-1039-y Delgado, 2011, Missense PANK2 mutation without “eye of the tiger” sign: MR findings in a large group of patients with pantothenate kinase-associated neurodegeneration (PKAN), Journal of Magnetic Resonance Imaging, 35, 788, 10.1002/jmri.22884 Deschauer, 2012, C19orf12 mutations in neurodegeneration with brain iron accumulation mimicking juvenile amyotrophic lateral sclerosis, Journal of Neurology, 259, 2434, 10.1007/s00415-012-6521-7 Dick, 2010, Mutation of FA2H underlies a complicated form of hereditary spastic paraplegia (SPG35), Human Mutation, 31, 10.1002/humu.21205 Di Fonzo, 2007, ATP13A2 missense mutations in juvenile parkinsonism and young onset Parkinson disease, Neurology, 68, 1557, 10.1212/01.wnl.0000260963.08711.08 Di Meo, 2018, Classification and molecular pathogenesis of NBIA syndromes, European Journal of Paediatric Neurology, 22, 272, 10.1016/j.ejpn.2018.01.008 Dorfman, 1978, Juvenile neuroaxonal dystrophy: Clinical, electrophysiological, and neuropathological features, Annals of Neurology, 3, 419, 10.1002/ana.410030511 Duell, 2018, Diagnosis, treatment, and clinical outcomes in 43 cases with cerebrotendinous xanthomatosis, Journal of Clinical Lipidology, 12, 1169, 10.1016/j.jacl.2018.06.008 Edvardson, 2008, Mutations in the fatty acid 2-hydroxylase gene are associated with leukodystrophy with spastic paraparesis and dystonia, The American Journal of Human Genetics, 83, 643, 10.1016/j.ajhg.2008.10.010 Giugliani, 2019, Clinical findings in Brazilian patients with adult GM1 gangliosidosis, JIMD Reports, 49, 96, 10.1002/jmd2.12067 Goker-Alpan, 2003, Phenotypic continuum in neuronopathic gaucher disease: An intermediate phenotype between type 2 and type 3, The Journal of Pediatrics, 143, 273, 10.1067/S0022-3476(03)00302-0 Grangeon, 2019, Biallelic MYORG mutation carriers exhibit primary brain calcification with a distinct phenotype, Brain, 142, 1573, 10.1093/brain/awz095 Gregory, 2008, Clinical and genetic delineation of neurodegeneration with brain iron accumulation, Journal of Medical Genetics, 46, 73, 10.1136/jmg.2008.061929 Grütz, 2016, Primary familial brain calcification in the ‘IBGC2’ kindred: All linkage roads lead toSLC20A2, Movement Disorders, 31, 1901, 10.1002/mds.26768 Haack, 2012, Exome sequencing reveals de novo WDR45 mutations causing a phenotypically distinct, X-linked dominant form of NBIA, The American Journal of Human Genetics, 91, 1144, 10.1016/j.ajhg.2012.10.019 Hartig, 2011, Absence of an orphan mitochondrial protein, C19orf12, causes a distinct clinical subtype of neurodegeneration with brain iron accumulation, The American Journal of Human Genetics, 89, 543, 10.1016/j.ajhg.2011.09.007 Hayflick, 2003, Genetic, clinical, and radiographic delineation of Hallervorden–Spatz syndrome, New England Journal of Medicine, 348, 33, 10.1056/NEJMoa020817 Hogarth, 2015, Neurodegeneration with brain iron accumulation: Diagnosis and management, Journal of Movement Disorders, 8, 1, 10.14802/jmd.14034 Imrie, 2007, The natural history of Niemann–Pick disease type C in the UK, Journal of Inherited Metabolic Disease, 30, 833, 10.1007/s10545-007-9986-2 Keller, 2013, Mutations in the gene encoding PDGF-B cause brain calcifications in humans and mice, Nature Genetics, 45, 1077, 10.1038/ng.2723 Klopstock, 2019, Safety and efficacy of deferiprone for pantothenate kinase-associated neurodegeneration: A randomised, double-blind, controlled trial and an open-label extension study, The Lancet Neurology, 18, 631, 10.1016/S1474-4422(19)30142-5 Koyama, 2017, Clinical and radiological diversity in genetically confirmed primary familial brain calcification, Scientific Reports, 7, 10.1038/s41598-017-11595-1 Kruer, 2010, Defective FA2H leads to a novel form of neurodegeneration with brain iron accumulation (NBIA), Annals of Neurology, 68, 611, 10.1002/ana.22122 Lachmann, 2011, Enzyme replacement therapy for lysosomal storage diseases, Current Opinion in Pediatrics, 23, 588 Landouré, 2013, Hereditary spastic paraplegia type 43 (SPG43) is caused by mutation inC19orf12, Human Mutation, 34, 1357, 10.1002/humu.22378 Legati, 2015, Mutations in XPR1 cause primary familial brain calcification associated with altered phosphate export, Nature Genetics, 47, 579, 10.1038/ng.3289 Litwin, 2012, Gender differences in Wilsons disease, Journal of the Neurological Sciences, 312, 31, 10.1016/j.jns.2011.08.028 Liu, 2016, Specifically neuropathic Gauchers mutations accelerate cognitive decline in Parkinsons, Annals of Neurology, 80, 674, 10.1002/ana.24781 Lorincz, 2009, Neurologic Wilsons disease, Annals of the New York Academy of Sciences, 1184, 173, 10.1111/j.1749-6632.2009.05109.x Machado, 2006, Neurological manifestations in Wilsons disease: Report of 119 cases, Movement Disorders, 21, 2192, 10.1002/mds.21170 Marti-Sanchez, 2018, Hypermanganesemia due to mutations in SLC39A14: Further insights into Mn deposition in the central nervous system, Orphanet Journal of Rare Diseases, 13, 10.1186/s13023-018-0758-x Merle, 2007, Clinical presentation, diagnosis and long-term outcome of Wilsons disease: A cohort study, Gut, 56, 115, 10.1136/gut.2005.087262 Muthane, 2004, Clinical features of adult GM1gangliosidosis: Report of three Indian patients and review of 40 cases, Movement Disorders, 19, 1334, 10.1002/mds.20193 Nakashima, 2016, WDR45 mutations in three male patients with West syndrome, Journal of Human Genetics, 61, 653, 10.1038/jhg.2016.27 Neumann, 2009, Glucocerebrosidase mutations in clinical and pathologically proven Parkinsons disease, Brain, 132, 1783, 10.1093/brain/awp044 Nicolas, 2015, Brain calcification process and phenotypes according to age and sex: Lessons fromSLC20A2,PDGFB, and PDGFRB mutation carriers, American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 168, 586, 10.1002/ajmg.b.32336 Nicolas, 2012, Mutation of the PDGFRB gene as a cause of idiopathic basal ganglia calcification, Neurology, 80, 181, 10.1212/WNL.0b013e31827ccf34 Paisan-Ruiz, 2008, Characterization of PLA2G6 as a locus for dystonia-parkinsonism, Annals of Neurology, 65, 19, 10.1002/ana.21415 Paschali, 2009, Dopamine transporter SPECT/CT and perfusion brain SPECT imaging in idiopathic basal ganglia calcinosis, Clinical Nuclear Medicine, 34, 421, 10.1097/RLU.0b013e3181a7d195 Patterson, 2015, Stable or improved neurological manifestations during miglustat therapy in patients from the international disease registry for Niemann-Pick disease type C: An observational cohort study, Orphanet Journal of Rare Diseases, 10, 10.1186/s13023-015-0284-z Pfeiffer, 2007, Wilsons disease, Seminars in Neurology, 27, 123, 10.1055/s-2007-971173 Prashanth, 2010, Do MRI features distinguish Wilsons disease from other early onset extrapyramidal disorders? An analysis of 100 cases, Movement Disorders, 25, 672, 10.1002/mds.22689 Quadri, 2012, Mutations in SLC30A10 cause parkinsonism and dystonia with hypermanganesemia, polycythemia, and chronic liver disease, The American Journal of Human Genetics, 90, 467, 10.1016/j.ajhg.2012.01.017 Ramos, 2018, Primary brain calcification: An international study reporting novel variants and associated phenotypes, European Journal of Human Genetics, 26, 1462, 10.1038/s41431-018-0185-4 Riboldi, 2019, GBA, gaucher disease, and Parkinson’s disease: From genetic to clinic to new therapeutic approaches, Cells, 8, 364, 10.3390/cells8040364 Roze, 2005, Dystonia and parkinsonism in GM1 type 3 gangliosidosis, Movement Disorders, 20, 1366, 10.1002/mds.20593 Schneider, 2016, Neurodegeneration with brain iron accumulation, Current Neurology and Neuroscience Reports, 16, 10.1007/s11910-015-0608-3 Schneider, 2011, Syndromes of neurodegeneration with brain iron accumulation (NBIA): An update on clinical presentations, histological and genetic underpinnings, and treatment considerations, Movement Disorders, 27, 42, 10.1002/mds.23971 Schneider, 2010, ATP13A2 mutations (PARK9) cause neurodegeneration with brain iron accumulation, Movement Disorders, 25, 979, 10.1002/mds.22947 Sevin, 2006, The adult form of Niemann-Pick disease type C, Brain, 130, 120, 10.1093/brain/awl260 Shivakumar, 2009, Teaching NeuroImages: Face of the giant panda and her cub: MRI correlates of Wilson disease, Neurology, 72, 10.1212/01.wnl.0000344409.73717.a1 Sidransky, 2009, Multicenter analysis of glucocerebrosidase mutations in Parkinson's disease, New England Journal of Medicine, 22, 1651, 10.1056/NEJMoa0901281 Spiegel, 2016, Severe infantile male encephalopathy is a result of early post-zygoticWDR45somatic mutation, Clinical Genetics, 90, 560, 10.1111/cge.12849 Stamelou, 2012, A new treatable genetic disorder of manganese metabolism causing dystonia-parkinsonism and cirrhosis: The “New” Wilsons disease?, Movement Disorders, 27, 962, 10.1002/mds.25031 Stamelou, 2013, Dystonic opisthotonus: A “red flag” for neurodegeneration with brain iron accumulation syndromes?, Movement Disorders, 28, 1325, 10.1002/mds.25490 Stelten, 2019, Movement disorders in cerebrotendinous xanthomatosis, Parkinsonism & Related Disorders, 58, 12, 10.1016/j.parkreldis.2018.07.006 Stige, 2018, Beta-propeller protein-associated neurodegeneration: A case report and review of the literature, Clinical Case Reports, 6, 353, 10.1002/ccr3.1358 Su, 2010, Cerebrotendinous xanthomatosis patients with and without parkinsonism: Clinical characteristics and neuroimaging findings, Movement Disorders, 25, 452, 10.1002/mds.22979 Tadic, 2015, Primary familial brain calcification with known gene mutations, JAMA Neurology, 72, 460, 10.1001/jamaneurol.2014.3889 Taly, 2007, Wilson disease, Medicine, 86, 112, 10.1097/MD.0b013e318045a00e Terbeek, 2017, Abnormal dopamine transporter imaging in adult-onset Niemann-Pick disease type C, Parkinsonism & Related Disorders, 36, 107, 10.1016/j.parkreldis.2016.12.029 Timmermann, 2010, Dystonia in neurodegeneration with brain iron accumulation: Outcome of bilateral pallidal stimulation, Brain, 133, 701, 10.1093/brain/awq022 Tuschl, 2016, Syndrome of hepatic cirrhosis, dystonia, polycythemia, and hypermanganesemia caused by mutations in SLC30A10, a manganese transporter in man, The American Journal of Human Genetics, 99, 521, 10.1016/j.ajhg.2016.07.015 Tuschl, 2016, Mutations in SLC39A14 disrupt manganese homeostasis and cause childhood-onset parkinsonism–dystonia, Nature Communications, 7, 10.1038/ncomms11601 Verhoeven, 2014, Beta-propeller protein-associated neurodegeneration (BPAN), a rare form of NBIA: Novel mutations and neuropsychiatric phenotype in three adult patients, Parkinsonism & Related Disorders, 20, 332, 10.1016/j.parkreldis.2013.11.019 Vrabelova, 2005, Mutation analysis of the ATP7B gene and genotype/phenotype correlation in 227 patients with Wilson disease, Molecular Genetics and Metabolism, 86, 277, 10.1016/j.ymgme.2005.05.004 Walshe, 1992, Wilsons disease: The problem of delayed diagnosis, Journal of Neurology, Neurosurgery & Psychiatry, 55, 692, 10.1136/jnnp.55.8.692 Wang, 2012, Mutations in SLC20A2 link familial idiopathic basal ganglia calcification with phosphate homeostasis, Nature Genetics, 44, 254, 10.1038/ng.1077 Wijburg, 2012, Development of a Suspicion Index to aid diagnosis of Niemann-Pick disease type C, Neurology, 78, 1560, 10.1212/WNL.0b013e3182563b82 Williams, 2005, Kufor Rakeb Disease: Autosomal recessive, levodopa-responsive parkinsonism with pyramidal degeneration, supranuclear gaze palsy, and dementia, Movement Disorders, 20, 1264, 10.1002/mds.20511 Yao, 2018, Biallelic mutations in MYORG cause autosomal recessive primary familial brain calcification, Neuron, 98, 10.1016/j.neuron.2018.05.037 Zhou, 2001, A novel pantothenate kinase gene (PANK2) is defective in Hallervorden-Spatz syndrome, Nature Genetics, 28, 345, 10.1038/ng572 Zhou, 2018, The asymmetry oZf neural symptoms in Wilsons disease patients detecting by diffusion tensor imaging, resting-state functional MRI, and susceptibility-weighted imaging, Brain and Behavior, 8, 10.1002/brb3.930